{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:18:14Z","timestamp":1789492694485,"version":"build-2803163510"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","funder":[{"name":"DORC International BV","award":["S67215"],"award-info":[{"award-number":["S67215"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To evaluate feasibility and safety of robot-assisted subretinal injections through attached retina using the comanipulated Mynutia system in patients with submacular hemorrhage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This prospective, single-center case series included 20 eyes undergoing vitrectomy with subretinal recombinant tissue plasminogen activator between June 2024 and August 2025. The EVA Inicio microinjection system with a 38-G needle was mounted on the Mynutia system. Injections were performed through attached retina when feasible. Primary outcomes were successful needle insertion, stable subretinal positioning for \u22653 minutes, safe withdrawal, and absence of device-associated adverse events (DAE). Secondary outcomes included injection parameters, hemorrhage displacement, visual outcomes, and complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Robot-assisted injection succeeded in all eyes; one required injection into the submacular hemorrhage because of anatomy. Mean injection duration was 178 \u00b1 34 seconds (max 400), but the needle tip was maintained in the subretinal space \u22653 minutes in all cases. No DAE occurred. Retinotomies closed spontaneously without visible reflux. Mean bleb initiation and propagation pressures were 10.3 \u00b1 3.2 and 3.0 [3.0\u20133.25] PSI, respectively; internal limiting membrane peeling reduced initiation pressure (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). Complete subfoveal displacement was achieved in 95%. Median BCVA improved from LogMAR 1.85 (counting fingers) to 0.66 (20\/90) at 6 weeks (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Adverse events included hyphema (5%), ocular hypertension (5%), vitreous hemorrhage (25%; 80% self-limited), RPE tear (20%), and recurrent submacular hemorrhage (5%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Robot-assisted subretinal injection with Mynutia is feasible and safe, enabling stable, prolonged low-pressure delivery through attached retina, and may enhance precision and tissue preservation in subretinal therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004745","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T20:00:10Z","timestamp":1768420810000},"page":"811-818","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["IN-HUMAN FEASIBILITY AND SAFETY OF SUBRETINAL DRUG INJECTION THROUGH ATTACHED RETINA USING A ROBOTIC COMANIPULATION SYSTEM"],"prefix":"10.1097","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6806-0734","authenticated-orcid":false,"given":"Ivo","family":"De Clerck","sequence":"first","affiliation":[{"name":"Military Hospital Queen Astrid, Brussels, Belgium;"},{"name":"University Hospitals Leuven, Leuven, Belgium; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Schoovaerts","sequence":"additional","affiliation":[{"name":"Faculty of Engineering, KU Leuven, Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Polidoro","sequence":"additional","affiliation":[{"name":"Faculty of Engineering, KU Leuven, Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouloud","family":"Ourak","sequence":"additional","affiliation":[{"name":"Faculty of Engineering, KU Leuven, Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Vander Poorten","sequence":"additional","affiliation":[{"name":"Faculty of Engineering, KU Leuven, Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Stalmans","sequence":"additional","affiliation":[{"name":"University Hospitals Leuven, Leuven, Belgium; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"R2-20260915","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/14656566.2025.2496424","article-title":"Beyond the injection: delivery systems reshaping retinal disease management","volume":"26","author":"Rowe","year":"2025","journal-title":"Expert Opin Pharmacother"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"xxv","DOI":"10.1016\/j.ajo.2018.08.038","article-title":"The blunt end: surgical challenges of gene therapy for inherited retinal diseases","volume":"196","author":"Davis","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000522110","article-title":"Controlled subretinal injection pressure prevents damage in pigs","volume":"245","author":"Olufsen","year":"2022","journal-title":"Ophthalmologica"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.oret.2023.08.017","article-title":"Classification and growth rate of chorioretinal atrophy after voretigene neparvovec-Rzyl for RPE65-Mediated retinal degeneration","volume":"8","author":"Bommakanti","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"846782","DOI":"10.3389\/fmed.2022.846782","article-title":"Subretinal therapy: technological solutions to surgical and immunological challenges","volume":"9","author":"Ladha","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.survophthal.2024.05.004","article-title":"Biomechanical considerations for optimising subretinal injections","volume":"69","author":"L'Abbate","year":"2024","journal-title":"Surv Ophthalmol"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/bjophthalmol-2021-321023","article-title":"Development of retinal atrophy after subretinal gene therapy with voretigene neparvovec","volume":"107","author":"Reichel","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"R10-20260915","first-page":"3598","article-title":"Design and Realisation of a Novel Robotic Manipulator for Retinal Surgery. 2013 IEEE\/RSJ International Conference on Intelligent Robots and Systems","author":"Gijbels","year":"2013"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/a-1315-1331","article-title":"Surgical aspects in gene therapy for inherited retinal diseases","volume":"238","author":"Fischer","year":"2021","journal-title":"Klin Monbl Augenheilkd"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000515118","article-title":"A comparative study of 23-Gauge and 27-Gauge vitrectomy for puckers or floaters, including evaluation of the effect of combined phaco-vitrectomy surgery on postoperative outcome","volume":"244","author":"Stalmans","year":"2021","journal-title":"Ophthalmologica"},{"issue":"5","key":"R13-20260915","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/24741264251359050","article-title":"Clinical performance of novel single-use lenses in vitreoretinal surgery","volume":"9","author":"De Clerck","year":"2025","journal-title":"J Vitreoretin Dis"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1007\/s10439-018-2053-3","article-title":"In-Human robot-assisted retinal vein cannulation, A world first","volume":"46","author":"Gijbels","year":"2018","journal-title":"Ann Biomed Eng"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-3-319-07058-2_12","article-title":"Design of 4-DOF parallelogram-based RCM mechanisms with a translational DOF implemented distal from the end-effector","volume":"22","author":"Gijbels","year":"2014","journal-title":"Mech Machine Sci"},{"key":"R16-20260915","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1167\/iovs.05-0981","article-title":"Visual acuities \u201chand motion\u201d and \u201ccounting fingers\u201d can be quantified with the freiburg visual acuity test","volume":"47","author":"Schulze-Bonsel","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/IAE.0000000000001029","article-title":"Novel technique for subretinal injection using local removal of the internal limiting membrane","volume":"36","author":"Okanouchi","year":"2016","journal-title":"RETINA"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41433-024-03149-3","article-title":"Robotising vitreoretinal surgeries","volume":"39","author":"Mi","year":"2025","journal-title":"Eye (Lond)"},{"key":"R19-20260915","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ajo.2021.11.011","article-title":"First-in-Human robot-assisted subretinal drug delivery under local anesthesia","volume":"237","author":"Cehajic-Kapetanovic","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/aos.14480","article-title":"Phase I trial on robot assisted retinal vein cannulation with ocriplasmin infusion for central retinal vein occlusion","volume":"99","author":"Willekens","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1097\/IAE.0000000000003857","article-title":"Intraoperative bleb behavior IN subretinal gene augmentation therapy for inherited retinal diseases","volume":"43","author":"Sisk","year":"2023","journal-title":"Retina"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41434-021-00294-2","article-title":"Injection pressure levels for creating blebs during subretinal gene therapy","volume":"29","author":"Scruggs","year":"2022","journal-title":"Gene Ther"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1109\/TMRB.2024.3464693","article-title":"Fast OCT-based needle tracking for retinal microsurgery using dynamic spiral scanning","volume":"6","author":"Xu","year":"2024","journal-title":"IEEE Trans Med Robotics Bionics"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11701-024-01991-x","article-title":"Sharper vision, steady hands: can robots improve subretinal drug delivery? Systematic review","volume":"18","author":"\u0141ajczak","year":"2024","journal-title":"J Robot Surg"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/eye.2017.158","article-title":"Technique of retinal gene therapy: delivery of viral vector into the subretinal space","volume":"31","author":"Xue","year":"2017","journal-title":"Eye (Lond)"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1167\/tvst.7.2.19","article-title":"Volumetric measurement of subretinal blebs using microscope-integrated optical coherence tomography","volume":"7","author":"Hsu","year":"2018","journal-title":"Transl Vis Sci Technol"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ajo.2025.02.018","article-title":"The 1-Step versus 2-Step subretinal Injection Trial (1,2-SIT)-A randomized controlled trial to compare drug reflux following subretinal injection","volume":"274","author":"Simunovic","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"R28-20260915","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/IAE.0000000000002800","article-title":"Sodium fluorescein as an optical label to evaluate subretinal injection","volume":"43","author":"Simunovic","year":"2023","journal-title":"Retina"},{"key":"R29-20260915","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1186\/s12886-022-02639-w","article-title":"Pars plana vitrectomy and subretinal tissue plasminogen activator for large exudative submacular hemorrhage: a case series","volume":"22","author":"Patikulsila","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"22139","DOI":"10.1038\/s41598-022-26289-6","article-title":"Displacement of submacular hemorrhage secondary to age-related macular degeneration with subretinal injection of air and tissue plasminogen activator","volume":"12","author":"Ogata","year":"2022","journal-title":"Sci Rep"},{"key":"R31-20260915","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13063-025-08727-8","article-title":"Vitrectomy, subretinal tissue plasminogen activator and intravitreal gas for submacular haemorrhage secondary to exudative age-related macular degeneration (TIGER): update to study protocol and addition of a statistical analysis plan and health economic analysis plan for a randomised controlled surgical trial","volume":"26","author":"Lee","year":"2025","journal-title":"Trials"},{"key":"R32-20260915","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.3390\/jcm9103088","article-title":"Management of a submacular hemorrhage secondary to age-related macular degeneration: a comparison of three treatment modalities","volume":"9","author":"Jeong","year":"2020","journal-title":"J Clin Med"},{"key":"R33-20260915","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13063-021-05966-3","article-title":"Vitrectomy, subretinal tissue plasminogen activator and intravitreal gas for submacular haemorrhage secondary to exudative age-related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial","volume":"23","author":"Jackson","year":"2022","journal-title":"Trials"},{"key":"R34-20260915","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.ophtha.2023.04.014","article-title":"Surgery, tissue plasminogen activator, antiangiogenic agents, and age-related macular degeneration study: a randomized controlled trial for submacular hemorrhage secondary to age-related macular degeneration","volume":"130","author":"Gabrielle","year":"2023","journal-title":"Ophthalmology"},{"key":"R35-20260915","doi-asserted-by":"crossref","first-page":"3160963","DOI":"10.1155\/2021\/3160963","article-title":"Visual outcome after vitrectomy with subretinal tPA injection to treat submacular hemorrhage secondary to age-related macular degeneration or macroaneurysm","volume":"2021","author":"Ali Said","year":"2021","journal-title":"J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:00:31Z","timestamp":1789491631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004745","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}